Albert Chon
Co-Founder & CTO at Injective · Team at > Ignite
Albert Chon is Co-founder and CTO of Injective Protocol, building the future of decentralized exchange. He was formerly a Consultant at OpenZeppelin and a Software Engineer at Amazon. For fun, he enjoys painting, skiing, photography, and learning about crypto, ML, cybersecurity, math, finance, psychology, longevity, cool tech, and new ways of thinking.
Current Roles
Investments
News Mentions
RT @injective: Native USDC is officially live on Injective. $77 Billion in regulated stablecoin liquidity from Circle can now be utilized…
RT @mirza: For anyone keeping track, Injective announced three Congresspeople coming to our Summit in Washington, DC in just a few days. G…
RT @injective: Native USDC is officially live on Injective. $77 Billion in regulated stablecoin liquidity from Circle can now be utilized…
Injective drives tokenized equities onchain with $3.57B in daily trading volume
累了，今天猪脚饭已完成。出门跑步去 1⃣上半年有跟着在injective铸造这个免费NFT的记得去看看，今天发现之前挂的30U，卖出去了3张🤣 https://rarible.com/injective/collections/0x816070929010a3d202d8a6b89f92bee33b7e8769 2⃣sahara最后一期解锁了，继续领取去卖 http://knowledgedrop.saharaai.com https://x.com/NinjaLabsCN/status/2015768298437382401
Get some fast facts about our latest spot listing: @injective 🥷 Staking for $INJ coming soon to @BinanceUS! 👀
Injective went big in America this past week. The Musicow collaboration unlocks $200B of music IP onchain in one of the largest tokenization efforts in crypto. Binance also listed $INJ in the U.S., regulated $INJ futures started trading on @Bitnomial's CFTC-regulated platform, and the CLARITY Act cl
Trading for $INJ is now live on @BinanceUS! What’s new: 🔸 Trading is available on the INJ/USDT pair 🔸 Deposit or withdraw INJ via the @Injective network 🔸 Staking for INJ coming soon!
The world's largest exchange and Injective's first ever partner, Binance has officially brought $INJ into the the US.Regulated. Made for America 🇺🇸
This past week, Injective became home to the world's largest regulated digital dollar. ICYMI, the first U.S.-regulated $